Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Athanassios Argiris; Shuli Li; Panayiotis Savvides; James P Ohr; Jill Gilbert; Marshall A Levine; Arnab Chakravarti; Missak Haigentz; Nabil F Saba; Chukwuemeka V Ikpeazu; Charles J Schneider; Harlan A Pinto; Arlene A Forastiere; Barbara Burtness